INOVIO PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
INOVIO PHARMACEUTICALS, INC. (INO) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $1.25 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-12
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.25M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.45M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.67M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.90M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $1.25M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.45M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $1.67M 10-K · filed 2026-03-12 |
| 2025-09-30 | $1.90M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $2.14M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $2.40M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.57M 10-K · filed 2025-03-18 |
| 2024-09-30 | $2.86M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.13M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $3.45M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $4.23M 10-K · filed 2024-03-06 |
| 2023-09-30 | $3.65M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.05M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $4.37M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $4.63M 10-K · filed 2023-03-01 |
| 2022-09-30 | $4.99M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $5.36M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $5.72M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $6.11M 10-K · filed 2022-03-01 |
| 2021-09-30 | $6.51M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $6.75M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $7.17M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $7.59M 10-K · filed 2021-03-01 |
| 2020-09-30 | $8.04M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $8.48M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $8.94M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $9.41M 10-K · filed 2020-03-12 |
| 2019-09-30 | $9.89M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $10.38M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $10.88M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |